These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 1331876

  • 1. Does the arteriovenous fistula in chronic haemodialysis patients stimulate endothelin-1 release?
    Wilkie ME, Khandan-Nia N, Ghatei MA, Bloom SR, Raftery MJ, Cunningham J.
    Nephrol Dial Transplant; 1992; 7(10):1019-21. PubMed ID: 1331876
    [Abstract] [Full Text] [Related]

  • 2. The advantages of end-to-side arteriovenous anastomosis over the other two types of arteriovenous anastomosis in dialysis patients.
    Galić G, Kvesić A, Tomić M, Rebac Z, Brekalo Z, Martinović V, Vuckov S.
    Coll Antropol; 2008 Mar; 32(1):109-14. PubMed ID: 18494195
    [Abstract] [Full Text] [Related]

  • 3. Autogenous saphenous vein AV fistulae for haemodialysis: eight years experience with 30 patients.
    Lornoy W, Becaus I, Gillardin JP, Cuvelier J, Schelstraete J, Vermaut M, Van Malderen P, Souffriau G.
    Proc Eur Dial Transplant Assoc; 1983 Mar; 19():227-33. PubMed ID: 6878236
    [Abstract] [Full Text] [Related]

  • 4. The pathogenesis of pulmonary hypertension in haemodialysis patients via arterio-venous access.
    Nakhoul F, Yigla M, Gilman R, Reisner SA, Abassi Z.
    Nephrol Dial Transplant; 2005 Aug; 20(8):1686-92. PubMed ID: 15840664
    [Abstract] [Full Text] [Related]

  • 5. [Study of vascular access (VA) by color Doppler ultrasonography (CDU). Comparison between delta-H and CDU methods in measuring VA blood flow rate].
    Roca-Tey R, Rivas A, Samon R, Ibrik O, Viladoms J.
    Nefrologia; 2005 Aug; 25(6):678-83. PubMed ID: 16514909
    [Abstract] [Full Text] [Related]

  • 6. Two-stage brachiobasilic arteriovenous fistula for chronic haemodialysis access.
    Francis DM, Lu Y, Robertson AJ, Millar RJ, Amy J.
    ANZ J Surg; 2007 Mar; 77(3):150-5. PubMed ID: 17305990
    [Abstract] [Full Text] [Related]

  • 7. Impact of switch of vascular access type on key clinical and laboratory parameters in chronic haemodialysis patients.
    Wystrychowski G, Kitzler TM, Thijssen S, Usvyat L, Kotanko P, Levin NW.
    Nephrol Dial Transplant; 2009 Jul; 24(7):2194-200. PubMed ID: 19228757
    [Abstract] [Full Text] [Related]

  • 8. Factors influencing the prevalence of central venous catheter use in a Canadian haemodialysis centre.
    Graham J, Hiremath S, Magner PO, Knoll GA, Burns KD.
    Nephrol Dial Transplant; 2008 Nov; 23(11):3585-91. PubMed ID: 18552397
    [Abstract] [Full Text] [Related]

  • 9. Comparison of hemodynamic changes associated with two different polytetraflouroethylene arteriovenous fistulae in hemodialysis patients.
    Karakayali H, Yagmurdur MC, Tutar NU, Basaran O, Haberal M.
    Transplant Proc; 2004 Nov; 36(9):2603-6. PubMed ID: 15621100
    [Abstract] [Full Text] [Related]

  • 10. Surgical bypass of symptomatic central venous obstruction for arteriovenous fistula salvage in hemodialysis patients.
    Suliman A, Greenberg JI, Angle N.
    Ann Vasc Surg; 2008 Mar; 22(2):203-9. PubMed ID: 18346573
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Recombinant tissue plasminogen activator (rt-PA) as first-line therapy for declotting of haemodialysis access.
    Andriani M, Drago G, Bernardi AM, Da Porto A, De Luca M, Riegler P, Biasia F, Pinzani A.
    Nephrol Dial Transplant; 1995 Mar; 10(9):1714-9. PubMed ID: 8559494
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Increasing the use of arteriovenous fistula in hemodialysis: economic benefits and economic barriers.
    Schon D, Blume SW, Niebauer K, Hollenbeak CS, de Lissovoy G.
    Clin J Am Soc Nephrol; 2007 Mar; 2(2):268-76. PubMed ID: 17699424
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Unraveling the realities of vascular access: the Network 11 experience.
    Besarab A, Adams M, Amatucci S, Bowe D, Deane J, Ketchen K, Reynolds K, Tello A.
    Adv Ren Replace Ther; 2000 Oct; 7(4 Suppl 1):S65-70. PubMed ID: 11053589
    [Abstract] [Full Text] [Related]

  • 19. Three-dimensional contrast-enhanced magnetic resonance angiography (3-D CE-MRA) in the evaluation of hemodialysis access complications, and the condition of central veins in patients who are candidates for hemodialysis access.
    Paksoy Y, Gormus N, Tercan MA.
    J Nephrol; 2004 Oct; 17(1):57-65. PubMed ID: 15151260
    [Abstract] [Full Text] [Related]

  • 20. Factors affecting the lifespan of autologous and synthetic arteriovenous access routes for haemodialysis.
    Lazarides MK, Iatrou CE, Karanikas ID, Kaperonis NM, Petras DI, Zirogiannis PN, Dayantas JN.
    Eur J Surg; 1996 Apr; 162(4):297-301. PubMed ID: 8739416
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.